Skip to main content
. 2017 Apr 24;61(5):e02464-16. doi: 10.1128/AAC.02464-16

TABLE 4.

Factors associated with treatment outcome

Factor Outcomea:
ORb (95% CI) P value for OR aOR (95% CI) P value for aOR
Favorable Unfavorable
Sex
    Male 1,056 (64.1) 235 (89) 4.54 (3.05–6.76) <0.001 1.92 (1.02–3.62) 0.043
    Female 592 (35.9) 29 (11) Reference Reference
Age (yr)
    18–59 1,519 (92.2) 235 (89) Reference 0.085 NSc NS
    ≥60 129 (7.8) 29 (11) 1.45 (0.95–2.22) NS NS
Smoker
    No 1,172 (71.1) 128 (48.5) Reference <0.001 NS NS
    Yes 476 (28.9) 136 (51.5) 2.62 (2.01–3.41) NS NS
Alcohol user
    No 1,077 (65.4) 93 (35.2) Reference <0.001 Reference <0.001
    Yes 571 (34.6) 171 (64.8) 3.47 (2.64–4.55) 2.17 (1.42–3.31)
Smear statusd
    Negative 515 (42.4) 59 (24) Reference <0.001 NS NS
    Positive 700 (57.6) 187 (76) 2.33 (1.7–3.19) NS NS
Diabetes
    No 1,251 (75.9) 209 (79.2) Reference 0.248 NS NS
    Yes 397 (24.1) 55 (20.8) 0.83 (0.6–1.14) NS NS
Baseline INH susceptibilitye
    Sensitive 687 (96.5) 147 (84) Reference <0.001 Reference <0.001
    Resistant 25 (3.5) 28 (16) 5.23 (2.97–9.24) 5.74 (3.12–10.59)
Body wt (kg) 49 (42–56) 45 (40–50) 0.96 (0.95–0.97) <0.001 0.96 (0.94–0.98) <0.001
Disease
    EPTB 637 (38.7) 34 (12.9) Reference <0.001 NS NS
    PTB 1,011 (61.3) 230 (87.1) 4.26 (2.93–6.19) NS NS
Category
    I 1,464 (88.8) 195 (73.9) Reference <0.001 Reference <0.001
    II 184 (11.2) 69 (26.1) 2.82 (2.06–3.86) 2.39 (1.56–3.65)
Concn (μg/ml) at 2 h postdosing
    RMP 2.3 (0.7–5) 2.1 (0.5–4.4) 0.97 (0.93–1.01) 0.140 0.94 (0.89–0.99) 0.036
    INH 7.4 (4.5–10.9) 8.4 (4.7–11.8) 1.02 (0.99–1.05) 0.116 NS NS
    PZA 33.3 (24–41.5) 35.8 (23.7–42.5) 0.99 (0.98–1.01) 0.726 NS NS
a

Data represent the number (percent) of patients for all factors except body weight and the concentration at 2 h postdosing, for which the data represent the median (IQR).

b

OR, odds ratio.

c

NS, not significant.

d

Data are only for pulmonary TB patients (n = 1,241).

e

Data are only for culture-positive cases (n = 651).